AstraZeneca reported $2.26B in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alcon AG ALC:SW USD 222M 36M
Amgen AMGN:US USD 2.66B 71M
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 2.26B 427M
AstraZeneca AZN:SS USD 2.26B 427M
Astrazeneca AZN:US USD 2.26B 427M
Bayer BAYN:GR EUR 1.35B 928M
Biogen BIIB:US USD 872.1M 68.8M
Bristol Myers Squibb BMY:US USD 2.74B 461M
Eli Lilly And LLY:US USD 1.95B 294.9M
Fresenius FRE:GR EUR 845M 54M
Fresenius Medical Care FME:GR EUR 269M 53M
Galapagos GLPG:NA EUR -37578000 38.75M
Genmab GEN:DC DKK 1.93B 684M
Gilead Sciences GILD:US USD 2.81B 784M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Hikma Pharmaceutical HIK:LN USD 256M 23M
Lonza Group LONN:SW CHF 698M 147M
Merck MRK:GR EUR 1.35B 3M
Merk MRK:US USD 5.56B 156M
Novartis NOVN:VX USD 3.33B 8M
Orion ORNBV:FH EUR 245.4M 163.4M
Pfizer PFE:US USD 9.7B 2.43B
Philips PHIA:NA EUR 105M 30M
Recordati REC:IM EUR 129.41M 6.95M
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M